Gene · 2621
NIH grants2,018
NIH grants whose papers are about the gene, through NIH's grant-paper links.
621 to 640 of 2,018
Download this page as JSON| Grant | Title | GAS6 papers | Newest fiscal year |
|---|---|---|---|
| R01CA214749 | MSC-Derived Exosomes and MicroRNA in Glioma Therapy | 2 | 2022 |
| R01CA227136 | Modeling and druggable-genome screening of glioblastoma invasion using regional biopsy-guided biomaterials systems | 2 | 2022 |
| R01DE026870 | Targeting the EGFR-PI3K/mTOR Signaling Circuitry: A Network-Based Approach for Oral Cancer Precision Therapy | 2 | 2022 |
| R01HL147095 | New driver of fibrosis and calcification in CAVD | 2 | 2022 |
| R56AI165991 | Decoding TGF-beta signaling pathways in skin langerhans cells | 2 | 2022 |
| T32GM007288 | Medical Scientist Training Program | 2 | 2022 |
| U54CA217378 | Complexity, Cooperation and Community in Cancer | 2 | 2022 |
| U54CA225088 | Systems Pharmacology of Therapeutic and Adverse Responses to ImmuneCheckpoint and Small Molecule Drugs | 2 | 2022 |
| F30CA239335 | Defining the stromal landscape that sustains AML drug resistance | 1 | 2022 |
| F31AA028743 | Hepatocyte-hepatic stellate cell axis in potentiation of alcohol and HIV-induced liver injury | 1 | 2022 |
| F31DK122724 | The Role of Macrophage Scavenger Receptor 1 in Type 2 Diabetes | 1 | 2022 |
| F31HL154727 | Matrix stiffness mediated biglycan expression in the tumor vasculature | 1 | 2022 |
| F32NS116205 | Understanding and Employing Innate Immune Cell Infiltration into the Brain Following Trauma | 1 | 2022 |
| I01BX003748 | Transplantable Micro-Tissue Engineered Neural Networks to Restore the Nigrostriatal Pathway in Parkinson's Disease | 1 | 2022 |
| IK6BX004597 | BLR&D Research Career Scientist Award Application for Xiao-Ming Xu, PhD | 1 | 2022 |
| K01AA026864 | Ethanol suppresses HBV peptide-MHC Class I presentation on hepatocytes | 1 | 2022 |
| K01EB028877 | Chimeric Antigen Receptor T Cell Design Through Living Cell Systems Biology | 1 | 2022 |
| K08HL141601 | Clinical significance and genetic determinants of novel imaging measures of emphysema distribution in 9,743 smokers | 1 | 2022 |
| K22CA237742 | Enhanced Immunotherapy by Targeting the Pros1:Macrophage Mer Axis | 1 | 2022 |
| K99DK131280 | Developmental lineages and functions of macrophages in white adipose tissue | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/grants?page=32